Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Common Equity (2016 - 2025)

Ultralife (ULBI) has 15 years of Common Equity data on record, last reported at $137.3 million in Q3 2025.

  • For Q3 2025, Common Equity rose 1.96% year-over-year to $137.3 million; the TTM value through Sep 2025 reached $137.3 million, up 1.96%, while the annual FY2024 figure was $134.0 million, 6.83% up from the prior year.
  • Common Equity reached $137.3 million in Q3 2025 per ULBI's latest filing, down from $138.6 million in the prior quarter.
  • Across five years, Common Equity topped out at $138.6 million in Q2 2025 and bottomed at $116.4 million in Q1 2023.
  • Average Common Equity over 4 years is $127.3 million, with a median of $127.2 million recorded in 2023.
  • Peak YoY movement for Common Equity: rose 11.42% in 2024, then grew 1.96% in 2025.
  • A 4-year view of Common Equity shows it stood at $118.4 million in 2021, then grew by 5.92% to $125.4 million in 2023, then rose by 6.83% to $134.0 million in 2024, then grew by 2.44% to $137.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $137.3 million in Q3 2025, $138.6 million in Q2 2025, and $136.6 million in Q1 2025.